MedTrace Logo

Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block

NCT06054945 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2023-09-29

No results posted yet for this study

Summary

In our clinic, routine suprainguinal fascia iliaca block (SIFIB) has been administered for postoperative analgesia in patients undergoing knee arthroplasty. Recently, we have introduced the IPACK (Infiltration between the Popliteal Artery and Capsule of the Knee) block to this regimen, and the aim of this retrospective study is to determine whether the addition of the IPACK block enhances the quality of analgesia.

Knee arthroplasty, also known as knee joint replacement surgery, is a common procedure performed to alleviate pain and improve joint function in patients with knee osteoarthritis or other knee-related conditions. Postoperative pain management is crucial for patient comfort and overall recovery.

In this study, we aimed to compare the two techniques mentioned earlier, namely the SIFIB (Suprainguinal Fascia Iliaca Block) and the SIFIB+IPACK, by examining the data of patients who underwent knee arthroplasty under spinal anesthesia at our clinic between January 1, 2023, and September 1, 2023.

Conditions

  • Analgesia
  • Pain Management
  • Acute Pain

Interventions

PROCEDURE

SIFIB (suprainguinal fascia iliaca block)

Ultrasound guided Suprainguinal Fascia Iliaca Block for Knee Arthroplasty Patients

OTHER

IPACK (Interspace between the popliteal artery and capsule of the posterior knee )

Ultrasound guided IPACK (Interspace between the popliteal artery and capsule of the posterior knee ) Block for Knee Arthroplasty Patients

DEVICE

Patient controlled anagesia device

Those who were administered opioids with PCA as rescue analgesic in the postoperative analgesia plan on the selected dates will be included in the study.

Sponsors & Collaborators

  • Samsun University

    lead OTHER

Principal Investigators

  • Hatice Kusderci, M.D. · Samsun University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-03
Primary Completion
2023-09-15
Completion
2023-09-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06054945 on ClinicalTrials.gov